Photo by fairytailphotography from unsplash
Cariprazine is an oral antipsychotic approved in the US for the treatment of schizophrenia, acute bipolar mania, and most recently, bipolar depression. The aim of this systematic review is to… Click to show full abstract
Cariprazine is an oral antipsychotic approved in the US for the treatment of schizophrenia, acute bipolar mania, and most recently, bipolar depression. The aim of this systematic review is to describe the efficacy, tolerability and safety of cariprazine for the treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults.
Keywords:
depression number;
bipolar depression;
cariprazine bipolar;
number;
number needed
Journal Title: International Journal of Clinical Practice
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Clinical Practice
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!